VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 213 filers reported holding VERACYTE INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460,422 | -10.8% | 20,619 | +1.7% | 0.00% | 0.0% |
| Q2 2023 | $516,150 | +11.3% | 20,265 | -2.5% | 0.00% | 0.0% |
| Q1 2023 | $463,617 | -3.3% | 20,790 | +2.9% | 0.00% | -20.0% |
| Q4 2022 | $479,275 | +48.8% | 20,197 | +4.0% | 0.01% | +66.7% |
| Q3 2022 | $322,000 | -15.9% | 19,415 | +0.8% | 0.00% | -25.0% |
| Q2 2022 | $383,000 | -27.6% | 19,253 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $529,000 | -32.7% | 19,204 | +0.7% | 0.00% | -33.3% |
| Q4 2021 | $786,000 | -7.6% | 19,070 | +4.1% | 0.01% | -14.3% |
| Q3 2021 | $851,000 | +16.9% | 18,318 | +0.6% | 0.01% | +16.7% |
| Q2 2021 | $728,000 | -28.8% | 18,213 | -4.2% | 0.01% | -33.3% |
| Q1 2021 | $1,022,000 | +27.3% | 19,018 | +15.9% | 0.01% | +28.6% |
| Q4 2020 | $803,000 | +44.7% | 16,409 | -3.9% | 0.01% | +16.7% |
| Q3 2020 | $555,000 | +101.1% | 17,073 | +60.1% | 0.01% | +50.0% |
| Q2 2020 | $276,000 | +4.2% | 10,665 | -2.1% | 0.00% | -20.0% |
| Q1 2020 | $265,000 | – | 10,893 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |